US FDA Adopts ICH Clinical Trials Guideline with Exclusive Reference to E2B(R3) Standards
Read more
CMDh Updates Guidelines to Implement Northern Ireland Protocol (Brexit relevant information)
Read more
US FDA announces that DTD version 3.3 will be made mandatory for eCTD submissions
Read more
Use of E2B(R3) Becomes Mandatory June 2022 - How to Prepare
Read more
EU Clinical Trials Regulation Now in Effect
Read more
EMA Updates Technical Guidance for eCTD Submissions in the EU
Read more
MHRA updates Guidance for Centrally Authorized Products (CAPs) to UK Marketing Authorization (MAs)
Read more
New EU Guidance on Data Submission for Investigational Medicines
Read more
Australia readies itself for eCTD only
Read more
China NMPA will be accepting eCTD submissions from 29th December 2021
Read more
Gens & Associates IDMP Vendor Assessment & Capability Survey - How does MPDmanager powered by CARA compare to competing products?
Read more
The FDA’s OPDP eCTD is now in effect - what does it mean for you?
Read more